3.50

3.86% 0.13

After Hours: 3.50

Aclarion Inc (ACON)

Overview News Price History Financials Discussions Forecast

Aclarion Inc stock is traded at $3.50, with a volume of 63,609. It is up +3.86% in the last 24 hours and up +2.34% over the past month. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Previous Close:

$3.37

Open:

$3.37

24h Volume:

63,609

Relative Volume:

0.63

Market Cap:

$8.62M

Revenue:

$75,700

Net Income/Loss:

$-7.23M

P/E Ratio:

-0.2034

EPS:

-17.2081

Net Cash Flow:

$-7.37M

1W Performance:

+10.76%

1M Performance:

+2.34%

6M Performance:

-51.19%

1Y Performance:

-47.41%

1-Day Range:

$3.32

$3.50

1-Week Range:

$2.88

$3.50

52-Week Range:

$2.3401

$12.03

Aclarion Inc Stock (ACON) Company Profile

Name

Aclarion Inc

Sector

Healthcare (1107)

Industry

Health Information Services (48)

Phone

833 275 2266

Address

8181 ARISTA PLACE, BROOMFIELD

Employee

Twitter

Next Earnings Date

2026-05-21

Latest SEC Filings

ACON's Discussions on Twitter

Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACON Aclarion Inc	3.50	8.30M	75,700	-7.23M	-7.37M	-17.21
VEEV Veeva Systems Inc	182.94	30.79B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	59.34	11.63B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	49.62	9.48B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	88.34	7.58B	1.31B	215.20M	408.32M	2.4627
HNGE Hinge Health Inc	58.48	4.71B	646.34M	-512.40M	202.76M	-6.6871

Aclarion Inc Stock (ACON) Latest News

Jun 01, 2026

Aclarion's Nociscan tech reveals immune-linked back pain subtypes, expanding precision spine care potential. - Pluang

Jun 01, 2026

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study - The Manila Times

Jun 01, 2026

Aclarion's Nociscan Technology Linked to Immune Signatures in Back Pain Study, Expanding Clinical Applications - Quiver Quantitative

Jun 01, 2026

Aclarion’s Nociscan technology used in back pain study - Investing.com

Jun 01, 2026

May 29, 2026

ACON Maintained by Ascendiant Capital -- Price Target Raised to $7.50 - GuruFocus

May 29, 2026

SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday - Benzinga

May 29, 2026

May 28, 2026

Aclarion Inc. Warrants (ACONW) Edge Lower as Tight Trading Range Persists at $0.03Algorithmic Stock Picks - thelegaladvocate.com

May 28, 2026

Aclarion: Board Will Determine Course of Action It Believes Is in Best Interests of Co, Hldrs >ACON - Moomoo

May 28, 2026

Aclarion to Review Echo Lake Capital’s Unsolicited Proposal - geneonline.com

May 28, 2026

Aclarion: Echo Lake Communication Contains Numerous Assertions Regarding Governance and Other Matters That Lack Important Context >ACON - Moomoo

May 28, 2026

Aclarion: Echo Lake Cap Offered to Acquire the Co for $4/Shr in Cash and Contingent Value Rights >ACON - Moomoo

May 28, 2026

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal - The Manila Times

May 28, 2026

Aclarion, Inc. Responds to Echo Lake Capital's Acquisition Proposal and Reaffirms Commitment to Shareholder Value - Quiver Quantitative

May 28, 2026

Aclarion says board to review Echo Lake Capital's acquisition proposal - marketscreener.com

May 28, 2026

Aclarion Says Board To Review Echo Lake Capital's Acquisition Proposal - TradingView

May 28, 2026

Echo Lake Capital Pressures Aclarion Board With Buyout Proposal and Reverse Merger Push - citybiz

May 28, 2026